ABOUT
SERVICES
NEWS & MEDIA
FORMS
POLICIES AND INFORMED CONSENT
HIPAA
PATIENT INTAKE
CONTACT
✕
PTSD
Home
PTSD
January 24, 2022
The Afterglow: Reflections on Phase 2 & 3 MDMA-Assisted Therapy for PTSD Trials
January 24, 2022
The Faces of Phase 3: Principal Investigators in MAPS’ Clinical Trials of MDMA-Assisted Therapy for PTSD
January 24, 2022
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study